A Neuralink patient is able to move computer cursors with his mind and even play first-person shooter video games, the firm says. New footage shared by Elon Musk's neurotech company shows how the ...

Elon Musk's cybernetic implant company, Neuralink, livestreamed video Wednesday of its first brain chip patient using his mind to play chess on a computer. Noland Arbaugh, a 29-year-old paralyzed ...

The third human to receive a Neuralink brain implant, who also has non-verbal ALS, is now able to speak in his own voice thanks to the advancing technology combined with Artificial Intelligence ...

The first patient to have a Neuralink chip implanted in their brain is opening up about the experience nearly two months after undergoing surgery. Noland Arbaugh, a quadriplegic, introduced ...

Neuralink even managed to get his link working with the Nintendo Switch so he could play Mario Kart. Arbaugh uses the implant to control a computer for 8 to 10 hours daily, something he could ...

Neuralink, Elon Musk’s neuroscience startup, live-streamed an interview with its first patient on Wednesday. The man in question, a 29-year-old quadriplegic who identifies himself as Noland ...

Elon Musk’s brain-computer interface company Neuralink has released a video purporting to show the first human subject using its brain implant to play chess on a laptop. The feature featured 29 ...

In the video, he said: “I was basically Batman stuck in a dark room.” The Neuralink implant offers him the freedom to communicate in brighter environments and at a much faster pace.

First human with Neuralink brain chip can play video game by ‘telepathy’ By . Allie Griffin. Published March 20, 2024, 10:50 p.m. ET.

The first ever human patient to be implanted with Elon Musk's Neuralink brain implant can play chess "just by thinking", new video has shown. The American company released a video showing 29-year ...

Elon Musk’s neurotechnology company Neuralink shared a video Wednesday showing its first patient playing chess with his mind. Quadriplegic Noland Arbaugh became the company’s inaugural patient ...

Neuralink has published an update on the second patient in its early human trials, and it said that "promisingly," it has "observed no thread retraction" in the participant.